skip nav
National Prevention Information Network
Search Help
Other Searches: Search Organizations | Search Materials | Search Campaign Resources | Search Funding
español
Share Share this page on Twitter Share this page on Facebook Share this page on LinkedIn View more options to share this page E-mail this page to a colleague Print this page


<< Back

Funding

HIV Vaccine Research and Design (HIVRAD) Program (P01)

Description
Grant Amount: Estimated total $5M for fiscal year 2015.

The HIVRAD program is designed to fund projects that further address hypotheses crucial to the design of an efficacious HIV/AIDS prophylactic vaccine. Applications for five years of support should include plans that have advanced past the exploratory stage and include preliminary data. Less fully developed applications can request less than 5 years of support to establish feasibility. Applications aimed at developing or optimizing a specific vaccine platform should lay out a research pathway with clear decision points. Extensive modeling of vaccine concepts in non-human primates may be included.

Clinical studies involving human subjects or vaccine research focused solely on therapeutic applications are not considered appropriate and will not be funded under this FOA. For information on programs that support therapeutic vaccine development, please contact program staff.

Applications may address, but need not be limited to:

Approaches to elicit durable and broadly neutralizing antibodies against HIV and/or SIV;
Identifying correlates of vaccine-induced immune protection to HIV/AIDS;
HIV structural studies as they relate to designing HIV immunogens;
Improved animal model systems (and challenge viruses) to address vaccine efficacy;
Approaches to increase the immunogenicity of HIV antigens (e.g., novel adjuvants);
How vaccine design can better address the heterogeneity of HIV;
Developing or improving viral or bacterial vaccine vectors;
Determining how immune cells can be mobilized to the portal of infection;
Investigations into the role of glycan structures on immunogenicity, antigenicity and infectivity;
Investigations into innate immunity to alter the outcome of infection.
Funding Organization
National Institute of Allergy and Infectious Diseases
Division of AIDS
Fund Category
HIV/AIDS
Support Types
Research
Locations
International
National
Eligible Organizations
City Agencies
Colleges/Universities
Commercial Organizations
Community Based Organizations
County Agencies
Educational Organizations/Institutions
Federal Government Agencies
International Agencies
IRS 501 (c)(3) Organizations
Nonprofit Organizations
Religious Organizations
Schools
State Agencies
Tribal Organizations
Number of Awards Given
1 - 3 awards
Award Amount Notes
NIH intends to fund an estimate of 1-3 awards, corresponding to a total of $5M, for fiscal year 2015. Future year amounts will depend on annual appropriations.
Letter of Intent Date
6/29/2014
Application Due Date
7/29/2014
Project Start Date
3/1/2015
Application Contact
GrantsInfo
,
Phone: (301) 435-0714
Technical Contact
Alan Schultz
NIAID
Phone: (240) 292-6169
Fund Duration
Up to 5 years.
Subjects
HIV/AIDS Prevention
Vaccine Development Research
Audiences
Researchers
Application Process
Applicants must download the SF424 (R&R) application package associated with this funding opportunity using the “Apply for Grant Electronically” button in this FOA or following the directions provided at Grants.gov.

It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide (http://grants.nih.gov/grants/funding/424/SF424_RR_Guide_General_Adobe_VerB.pdf), except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Web Site
http://grants.nih.gov/grants/guide/pa-files/PAR-14-206.html
Fund Number
PAR-14-206

Disclaimer: NPIN provides this information as a public service only. The views and information provided about the materials, funding opportunities, and organizations do not necessarily state or reflect those of the U.S. Department of Health and Human Services, CDC, or NPIN.

cdcnpin.org Fund Record #4834

<< Back

CDCNPIN.org

Contact Us
About Us
HIV Content Notice
Privacy Policy
Policies & Disclaimers
Site Index
Help Using the CDC NPIN Web Site

CDC NPIN Searches

Search Organizations
Search Materials
Search Funding Opportunities
Search Campaign Resources
Help Using the CDC NPIN Searches

CDC NPIN Resources

hivtest.cdc.gov
m.hivtest.cdc.gov
findtbresources.org
STD Awareness Microsite
findstdtest.org
AIDS Gov Logo and Link CDC Logo and Link